Nathalie Laarakker

Direktor/Vorstandsmitglied bei OXURION NV

Health Technology

Consumer Services

Aktive Positionen von Nathalie Laarakker

Unternehmen	Position	Beginn	Ende
OXURION NV	Direktor/Vorstandsmitglied	02.05.2023	-
OXURION NV	Independent Dir/Board Member	02.05.2023	-
Intravacc BV	Direktor/Vorstandsmitglied	01.04.2021	-
Intravacc BV	Finanzdirektor/CFO	01.04.2021	-

Unternehmen	Position	Beginn	Ende
MERUS N.V.	Corporate Officer/Principal	-	-
Gadeta BV Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands.	Corporate Officer/Principal	01.01.2018	-

University of Amsterdam

Undergraduate Degree

International

Niederlande	5
Belgien	2

Operativ

Director/Board Member	2
Corporate Officer/Principal	2
Independent Dir/Board Member	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
OXURION NV	Health Technology
MERUS N.V.	Health Technology

Private Unternehmen	2
Gadeta BV Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands.	Health Technology
Intravacc BV	Health Technology

Private Unternehmen

Health Technology

Intravacc BV

Health Technology